GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide modulate appetite, satiety, and gastric emptying, documented across STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Permet d'avoir un regain d'nergie
Achieving significant weight loss often requires making changes to one's diet and exercise routine
Cavallini G, Modenini F, Vitali G, Koverech A
Sample meals for days 2-4: Mini-meal 1 (7-8am): Protein smoothie (20g protein powder, banana, almond milk, spinach) Mini-meal 2 (10-11am): cup Greek yogurt with cup berries Mini-meal 3 (1-2pm): 3 oz grilled chicken breast, cup plain white rice, cup steamed carrots Mini-meal 4 (4-5pm): 2 hard-boiled eggs, 5 whole grain crackers Mini-meal 5 (7-8pm): 4 oz white fish (cod or tilapia), cup mashed sweet potato, small side salad Key strategy: Eat slowly